Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of Velcade in reversal of endocrine resistance in hormone receptor-positive metastatic breast cancer
ISRCTN55808957Phase 2Completed
- Sponsor
- St. Augustinus-Krankenhaus
- Start
- Jan 2007
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bortezomib in breast cancer, sponsored by St. Augustinus-Krankenhaus. Started Jan 2007; status: completed.
02
Drugs
bortezomib
03
Conditions
breast cancer
Beyond the preview
Go deeper on ISRCTN55808957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN55808957.